Publications by authors named "Nicolas Mylonakis"

Claim this Profile
D
Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines.
Christos Kosmas, Nicolas Tsavaris, Nikolaos Malamos, George Tsakonas, Argyris Gassiamis, Nicolas Mylonakis

Invest New Drugs· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse calcification of metastases after intensive multiagent chemotherapy in widespread osteosarcoma leading to death in a 18-year-old male: report of a case and literature review.
Argyris Gassiamis, George Tsakonas, Georgia Soukouli, Nicolas Mylonakis, Athanasios Karabelis

Med Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Christos Kosmas, Nicolas Tsavaris, Konstantinos Syrigos, Angelos Koutras, George Tsakonas, Nicolas Mylonakis

Cancer Chemother Pharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare and aggressive metastatic, axial multifocal local epithelioid sarcoma associated with paraneoplastic granulocytosis and hypoglycaemia.
George P Tsakonas, Manolis S Kallistratos, Eugenia K Balamoti, Argyris Gassiamis, Adamadia Zizi-Sermpetzoglou, Nicolas Mylonakis

Lancet Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
Christos Kosmas, Nicolas Tsavaris, Aggelos Koutras, Thomas Makatsoris, Nicolas Mylonakis

Oncology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Christos Kosmas, Nicolas B Tsavaris, Georgia Soukouli, Panagiotis Gouveris, George Tsakonas, Nicolas Mylonakis

Med Oncol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Christos Kosmas, Nicolas B Tsavaris, George Tsakonas, Georgia Soukouli, Argyris Gassiamis, Nicolas Mylonakis

Med Sci Monit· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.
Christos Kosmas, Nicolas Tsavaris, Nicolas Mylonakis, Haralambos P Kalofonos

Crit Rev Oncol Hematol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis